A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH
Clinical trial NCT05591079 · COMPLETED
Trial details
- NCT number
- NCT05591079
- Sponsor
- Cascade Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2023-11-09
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.